ReviewCurrent oncology reports2015
Ductal Carcinoma In Situ: Treatment Update and Current Trends.
Review in Current oncology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Endocrine Therapy for Ductal Carcinoma In Situ (DCIS) of the Breast with Breast Conserving Surgery (BCS) and Radiotherapy (RT): a Meta-Analysis.Pathology oncology research : POR · 2020Pooled it
- Lumpectomy surgery for large ductal carcinoma in situ.Breast cancer research and treatment · 2025Article
- Imaging Changes and Outcomes of Patients Undergoing Active Monitoring for Ductal Carcinoma In Situ: Seven-Year Follow-up Study.Academic radiology · 2024Article
- Granulomatous mastitis masking ductal carcinoma in situ: A case report with literature review.Biomedical reports · 2024Article
- Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.AJR. American journal of roentgenology · 2021Article
- The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ.British journal of cancer · 2020Article
- Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance.Academic radiology · 2020Article
- Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?Annals of surgical oncology · 2020Article
- Identifying opportunities to support patient-centred care for ductal carcinoma in situ: qualitative interviews with clinicians.BMC cancer · 2020Article
- Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?Journal of magnetic resonance imaging : JMRI · 2017Article
- Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinomaOncotarget · 2017Article
- Docking ofOncotarget · 2017Article
- Diagnostic value of endoscopic appearance during ductoscopy in patients with pathological nipple discharge.BMC cancer · 2017Article
- The Role of Sentinel Lymph Node Biopsy in Patients With B5c Breast Cancer Diagnosis.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ductal carcinoma in situ (DCIS) traditionally has been managed through various combinations of surgery, radiation, and endocrine therapy. However, concern for under- or over-treatment of DCIS has led many surgeons to question historically standardized approaches and instead begin to tailor treatment based on individual prognostic indicators. Recent and ongoing clinical trials have investigated the potential for active surveillance in DCIS, the possibility of eliminating radiation therapy (RT), and ways in which adjuvant systemic therapy may be refined. This review will summarize the current trends in the treatment of DCIS, as well as highlight the most pertinent clinical trials that are shaping management today.
Indexed as
Identifiers
26373411What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.